Cargando…

Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis

Numerous vaccines have been evaluated and approved for coronavirus disease 2019 (COVID-19). Since pregnant persons have been excluded from most clinical trials of COVID-19 vaccines, sufficient data regarding the safety of these vaccines for the pregnant person and their fetus have rarely been availa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciapponi, Agustín, Berrueta, Mabel, Ballivian, Jamile, Bardach, Ariel, Mazzoni, Agustina, Anderson, Steven, Argento, Fernando J., Bok, Karin, Comandé, Daniel, Goucher, Erin, Kampmann, Beate, Parker, Edward P. K., Rodriguez-Cairoli, Federico, Santa Maria, Victoria, Stergachis, Andy, Voss, Gerald, Xiong, Xu, Zaraa, Sabra, Munoz, Flor M., Karron, Ruth A., Gottlieb, Sami L., Buekens, Pierre M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981247/
https://www.ncbi.nlm.nih.gov/pubmed/36862871
http://dx.doi.org/10.1097/MD.0000000000032954
_version_ 1784900060528508928
author Ciapponi, Agustín
Berrueta, Mabel
Ballivian, Jamile
Bardach, Ariel
Mazzoni, Agustina
Anderson, Steven
Argento, Fernando J.
Bok, Karin
Comandé, Daniel
Goucher, Erin
Kampmann, Beate
Parker, Edward P. K.
Rodriguez-Cairoli, Federico
Santa Maria, Victoria
Stergachis, Andy
Voss, Gerald
Xiong, Xu
Zaraa, Sabra
Munoz, Flor M.
Karron, Ruth A.
Gottlieb, Sami L.
Buekens, Pierre M.
author_facet Ciapponi, Agustín
Berrueta, Mabel
Ballivian, Jamile
Bardach, Ariel
Mazzoni, Agustina
Anderson, Steven
Argento, Fernando J.
Bok, Karin
Comandé, Daniel
Goucher, Erin
Kampmann, Beate
Parker, Edward P. K.
Rodriguez-Cairoli, Federico
Santa Maria, Victoria
Stergachis, Andy
Voss, Gerald
Xiong, Xu
Zaraa, Sabra
Munoz, Flor M.
Karron, Ruth A.
Gottlieb, Sami L.
Buekens, Pierre M.
author_sort Ciapponi, Agustín
collection PubMed
description Numerous vaccines have been evaluated and approved for coronavirus disease 2019 (COVID-19). Since pregnant persons have been excluded from most clinical trials of COVID-19 vaccines, sufficient data regarding the safety of these vaccines for the pregnant person and their fetus have rarely been available at the time of product licensure. However, as COVID-19 vaccines have been deployed, data on the safety, reactogenicity, immunogenicity, and efficacy of COVID-19 vaccines for pregnant persons and neonates are becoming increasingly available. A living systematic review and meta-analysis of the safety and effectiveness of COVID-19 vaccines for pregnant persons and newborns could provide the information necessary to help guide vaccine policy decisions. METHODS AND ANALYSIS: We aim to conduct a living systematic review and meta-analysis based on biweekly searches of medical databases (e.g., MEDLINE, EMBASE, CENTRAL) and clinical trial registries to systematically identify relevant studies of COVID-19 vaccines for pregnant persons. Pairs of reviewers will independently select, extract data, and conduct risk of bias assessments. We will include randomized clinical trials, quasi-experimental studies, cohort, case-control, cross-sectional studies, and case reports. Primary outcomes will be the safety, efficacy, and effectiveness of COVID-19 vaccines in pregnant persons, including neonatal outcomes. Secondary outcomes will be immunogenicity and reactogenicity. We will conduct paired meta-analyses, including prespecified subgroup and sensitivity analyses. We will use the grading of recommendations assessment, development, and evaluation approach to evaluate the certainty of evidence.
format Online
Article
Text
id pubmed-9981247
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-99812472023-03-03 Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis Ciapponi, Agustín Berrueta, Mabel Ballivian, Jamile Bardach, Ariel Mazzoni, Agustina Anderson, Steven Argento, Fernando J. Bok, Karin Comandé, Daniel Goucher, Erin Kampmann, Beate Parker, Edward P. K. Rodriguez-Cairoli, Federico Santa Maria, Victoria Stergachis, Andy Voss, Gerald Xiong, Xu Zaraa, Sabra Munoz, Flor M. Karron, Ruth A. Gottlieb, Sami L. Buekens, Pierre M. Medicine (Baltimore) 5600 Numerous vaccines have been evaluated and approved for coronavirus disease 2019 (COVID-19). Since pregnant persons have been excluded from most clinical trials of COVID-19 vaccines, sufficient data regarding the safety of these vaccines for the pregnant person and their fetus have rarely been available at the time of product licensure. However, as COVID-19 vaccines have been deployed, data on the safety, reactogenicity, immunogenicity, and efficacy of COVID-19 vaccines for pregnant persons and neonates are becoming increasingly available. A living systematic review and meta-analysis of the safety and effectiveness of COVID-19 vaccines for pregnant persons and newborns could provide the information necessary to help guide vaccine policy decisions. METHODS AND ANALYSIS: We aim to conduct a living systematic review and meta-analysis based on biweekly searches of medical databases (e.g., MEDLINE, EMBASE, CENTRAL) and clinical trial registries to systematically identify relevant studies of COVID-19 vaccines for pregnant persons. Pairs of reviewers will independently select, extract data, and conduct risk of bias assessments. We will include randomized clinical trials, quasi-experimental studies, cohort, case-control, cross-sectional studies, and case reports. Primary outcomes will be the safety, efficacy, and effectiveness of COVID-19 vaccines in pregnant persons, including neonatal outcomes. Secondary outcomes will be immunogenicity and reactogenicity. We will conduct paired meta-analyses, including prespecified subgroup and sensitivity analyses. We will use the grading of recommendations assessment, development, and evaluation approach to evaluate the certainty of evidence. Lippincott Williams & Wilkins 2023-03-03 /pmc/articles/PMC9981247/ /pubmed/36862871 http://dx.doi.org/10.1097/MD.0000000000032954 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 5600
Ciapponi, Agustín
Berrueta, Mabel
Ballivian, Jamile
Bardach, Ariel
Mazzoni, Agustina
Anderson, Steven
Argento, Fernando J.
Bok, Karin
Comandé, Daniel
Goucher, Erin
Kampmann, Beate
Parker, Edward P. K.
Rodriguez-Cairoli, Federico
Santa Maria, Victoria
Stergachis, Andy
Voss, Gerald
Xiong, Xu
Zaraa, Sabra
Munoz, Flor M.
Karron, Ruth A.
Gottlieb, Sami L.
Buekens, Pierre M.
Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis
title Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis
title_full Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis
title_fullStr Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis
title_full_unstemmed Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis
title_short Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis
title_sort safety, immunogenicity, and effectiveness of covid-19 vaccines for pregnant persons: a protocol for systematic review and meta analysis
topic 5600
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981247/
https://www.ncbi.nlm.nih.gov/pubmed/36862871
http://dx.doi.org/10.1097/MD.0000000000032954
work_keys_str_mv AT ciapponiagustin safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT berruetamabel safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT ballivianjamile safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT bardachariel safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT mazzoniagustina safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT andersonsteven safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT argentofernandoj safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT bokkarin safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT comandedaniel safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT gouchererin safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT kampmannbeate safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT parkeredwardpk safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT rodriguezcairolifederico safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT santamariavictoria safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT stergachisandy safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT vossgerald safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT xiongxu safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT zaraasabra safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT munozflorm safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT karronrutha safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT gottliebsamil safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis
AT buekenspierrem safetyimmunogenicityandeffectivenessofcovid19vaccinesforpregnantpersonsaprotocolforsystematicreviewandmetaanalysis